Whitehawk Therapeutics (WHWK) Shares Outstanding (Diluted Average) (2019 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $61.9 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $61.9 million, up 128.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $61.9 million (up 128.96% YoY), and the FY2025 annual result was $61.9 million, up 128.96% from the prior year.
• Shares Outstanding (Diluted Average) advanced to $61.9 million in Q4 2025 per WHWK's latest filing, from $39.9 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $61.9 million in Q4 2025 and troughed at $2.5 million in Q2 2021.
• A 5-year average of $24.9 million and a median of $26.9 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Diluted Average) sank 93.78% in 2021, then soared 723.76% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $8.9 million in 2021, then soared by 152.27% to $22.5 million in 2022, then rose by 19.58% to $26.9 million in 2023, then increased by 0.42% to $27.0 million in 2024, then surged by 128.96% to $61.9 million in 2025.
• Business Quant data shows WHWK's Shares Outstanding (Diluted Average) at $61.9 million in Q4 2025, $39.9 million in Q1 2025, and $27.0 million in Q4 2024.